Print

Daiichi Sankyo Co Ltd. Says U.S. FDA Rejects Anaemia Drug  
3/12/2008 8:46:01 AM

TOKYO, March 12 (Reuters) - U.S. regulators have rejected Daiichi Sankyo Co Ltd's injectable anaemia drug Injectafer for the broad treatment of uterine bleeding and in a surprise move also knocked it back for a narrower use.
//-->